AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 69 filers reported holding AADI BIOSCIENCE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,791,252 | -29.2% | 989,928 | 0.0% | 0.03% | -28.2% |
Q2 2023 | $6,771,108 | -5.5% | 989,928 | 0.0% | 0.04% | 0.0% |
Q1 2023 | $7,167,079 | -43.6% | 989,928 | 0.0% | 0.04% | -48.7% |
Q4 2022 | $12,700,776 | -9.2% | 989,928 | 0.0% | 0.08% | -17.4% |
Q3 2022 | $13,988,000 | – | 989,928 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 26,666 | $644,000 | 37.25% |
ACUTA CAPITAL PARTNERS, LLC | 1,529,402 | $36,935,000 | 15.52% |
Alerce Investment Management, L.P. | 374,785 | $9,051,000 | 9.21% |
VR Adviser, LLC | 1,529,402 | $36,935,000 | 5.05% |
Vivo Capital, LLC | 1,303,390 | $31,477,000 | 1.90% |
Ghost Tree Capital, LLC | 200,000 | $4,830,000 | 1.73% |
BVF INC/IL | 899,392 | $21,720,000 | 0.79% |
HighVista Strategies LLC | 40,549 | $979,000 | 0.78% |
Avoro Capital Advisors LLC | 1,829,402 | $44,180,000 | 0.75% |
Ikarian Capital, LLC | 196,408 | $4,744,000 | 0.71% |